Pamela J. Cramer - Aug 19, 2022 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Human Resources Officer
Signature
/s/ Hunter Smith, attorney-in-fact for Pamela J. Cramer
Stock symbol
RYTM
Transactions as of
Aug 19, 2022
Transactions value $
-$78,394
Form type
4
Date filed
8/23/2022, 04:30 PM
Previous filing
Jul 28, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $257K +13.5K +606.7% $19.02 15.7K Aug 19, 2022 Direct
transaction RYTM Common Stock Sale -$335K -13.5K -85.85% $24.83 2.22K Aug 19, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Options Exercise $0 -13.5K -17.99% $0.00 61.5K Aug 19, 2022 Common Stock 13.5K $19.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $24.79 to $24.86. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
F2 The stock options were granted on July 26, 2021. 25% of the shares subject to the option vest and became exercisable on July 26, 2022 and the remaining 75% of the shares subject to the option vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.